Patents by Inventor Leisa JACKSON

Leisa JACKSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS CoV-2 INFECTIVITY DETERMINATION ASSAY
    Publication number: 20220259680
    Abstract: Methods and compositions for characterizing a biological sample (e.g., comprising an infectious agent) from a subject are provided. Methods can include detecting linkage of nucleic acids that are linked in a viable cell or organism but that become degraded and thus unlinked in inviable cells or organisms and then characterizing the subject based on the quantity of linked and unlinked sequences.
    Type: Application
    Filed: February 14, 2022
    Publication date: August 18, 2022
    Inventors: Dianna MAAR, Monica HERRERA, George KARLIN-NEUMANN, Josh SHINOFF, Audrey AUDETAT, Scott HUTTON, Hestia MELLERT, Leisa JACKSON, Gary PESTANO
  • Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
    Patent number: 10870891
    Abstract: The present disclosure relates to a rapid diagnostic test system that includes the prospective collection of whole blood, preservation of circulating nucleic acids at ambient temperature, and the reproducible detection of nucleic acids including DNA and mRNA (including fusion transcripts and differentially expressed transcripts) by different genomic methodologies.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: December 22, 2020
    Assignee: BIODESIX, INC.
    Inventors: Hestia Mellert, Leisa Jackson, Gary A. Pestano
  • DIAGNOSTIC TEST STYSTEM FOR SPECIFIC, SENSITIVE AND REPRODUCIBLE DETECTION OF CIRCULATING NUCLEIC ACIDS IN WHOLE BLOOD
    Publication number: 20180202005
    Abstract: The present disclosure relates to a rapid diagnostic test system that includes the prospective collection of whole blood, preservation of circulating nucleic acids at ambient temperature, and the reproducible detection of nucleic acids including DNA and mRNA (including fusion transcripts and differentially expressed transcripts) by different genomic methodologies.
    Type: Application
    Filed: January 5, 2018
    Publication date: July 19, 2018
    Applicant: Biodesix, Inc.
    Inventors: Hestia MELLERT, Leisa JACKSON, Gary A. PESTANO